1. Home
  2. DVA vs JBL Comparison

DVA vs JBL Comparison

Compare DVA & JBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • JBL
  • Stock Information
  • Founded
  • DVA 1994
  • JBL 1966
  • Country
  • DVA United States
  • JBL United States
  • Employees
  • DVA N/A
  • JBL N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • JBL Electrical Products
  • Sector
  • DVA Health Care
  • JBL Technology
  • Exchange
  • DVA Nasdaq
  • JBL Nasdaq
  • Market Cap
  • DVA 12.2B
  • JBL 14.1B
  • IPO Year
  • DVA 1995
  • JBL 1993
  • Fundamental
  • Price
  • DVA $165.51
  • JBL $131.09
  • Analyst Decision
  • DVA Hold
  • JBL Buy
  • Analyst Count
  • DVA 5
  • JBL 7
  • Target Price
  • DVA $153.40
  • JBL $143.50
  • AVG Volume (30 Days)
  • DVA 1.0M
  • JBL 1.2M
  • Earning Date
  • DVA 10-29-2024
  • JBL 12-12-2024
  • Dividend Yield
  • DVA N/A
  • JBL 0.24%
  • EPS Growth
  • DVA 41.03
  • JBL 85.55
  • EPS
  • DVA 9.24
  • JBL 11.17
  • Revenue
  • DVA $12,666,614,000.00
  • JBL $28,883,000,000.00
  • Revenue This Year
  • DVA $6.17
  • JBL N/A
  • Revenue Next Year
  • DVA $3.56
  • JBL $5.60
  • P/E Ratio
  • DVA $17.90
  • JBL $11.74
  • Revenue Growth
  • DVA 6.34
  • JBL N/A
  • 52 Week Low
  • DVA $98.26
  • JBL $95.85
  • 52 Week High
  • DVA $168.50
  • JBL $156.94
  • Technical
  • Relative Strength Index (RSI)
  • DVA 62.72
  • JBL 58.30
  • Support Level
  • DVA $154.05
  • JBL $126.06
  • Resistance Level
  • DVA $161.80
  • JBL $131.79
  • Average True Range (ATR)
  • DVA 4.24
  • JBL 2.61
  • MACD
  • DVA 1.71
  • JBL -0.65
  • Stochastic Oscillator
  • DVA 96.71
  • JBL 38.25

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

About JBL Jabil Inc.

Jabil Inc is a United States-based company engaged in providing manufacturing services and solutions. It provides comprehensive electronics design, production and product management services to companies in various industries and end markets.The Company derives its revenue from providing comprehensive electronics design, production and product management services. It operates in two segments. The Electronics Manufacturing Services (EMS) segment, which is the key revenue driver, is focused on leveraging IT, supply chain design and engineering, technologies largely centered on core electronics. The Diversified Manufacturing Services (DMS) segment is focused on providing engineering solutions, with an emphasis on material sciences, technologies, and healthcare.

Share on Social Networks: